| 000 | 01211 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516223458.0 | ||
| 264 | 0 | _c20140804 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2014.8606 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathers, Bradley M | |
| 245 | 0 | 0 |
_aIntegrating HIV prevention into practice. _h[electronic resource] |
| 260 |
_bJAMA _c |
||
| 300 |
_a349-50 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aEmtricitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdiagnosis |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrganophosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xprevention & control |
| 650 | 0 | 4 | _aTenofovir |
| 700 | 1 | _aCooper, David A | |
| 773 | 0 |
_tJAMA _gvol. 312 _gno. 4 _gp. 349-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2014.8606 _zAvailable from publisher's website |
| 999 |
_c24020169 _d24020169 |
||